SCHEMBL1011075

SCHEMBL1011075

COc1cccc(CN2C=CN(C)C2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPO P22079 3/20 0.54
SIGMAR1 Q99720 2/20 0.54
CMA1 P23946 1/20 0.53
KDM4E B2RXH2 3/20 0.51
ALDH1A1 P00352 3/20 0.51
MAPT P10636 2/20 0.49
LMNA P02545 1/20 0.49
TP53 P04637 1/20 0.49
HRH3 Q9Y5N1 1/20 0.49
TAAR1 Q96RJ0 1/20 0.49
GAA P10253 1/20 0.46
IDO1 P14902 1/20 0.45
AGXT P21549 1/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
POLB P06746 1/20 0.45
HPGD P15428 1/20 0.45
MAPK1 P28482 1/20 0.45
ATM Q13315 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31177907 1.00 LPO (0.54) LPOSIGMAR1CMA1KDM4EALDH1A1
Bromide SCHEMBL2194872 0.98 LPO (0.52) LPOSIGMAR1CMA1KDM4EALDH1A1
Hydrochloric Acid SCHEMBL2011319 0.98 LPO (0.52) LPOSIGMAR1CMA1KDM4EALDH1A1
Hydrochloric Acid SCHEMBL31177921 0.98 LPO (0.52) LPOSIGMAR1CMA1KDM4EALDH1A1
SCHEMBL10522098 0.87 SIGMAR1 (0.61) SIGMAR1HRH3TAAR1
SCHEMBL1009271 0.81 SIGMAR1 (0.47) SIGMAR1CMA1KDM4EALDH1A1MAPT
Bromide SCHEMBL2196195 0.80 SIGMAR1 (0.46) SIGMAR1CMA1KDM4EALDH1A1MAPT
SCHEMBL31177901 0.80 POLB (0.45) KDM4EALDH1A1MAPTTP53HRH3
SCHEMBL28299282 0.80 POLB (0.45) KDM4EALDH1A1MAPTTP53HRH3
SCHEMBL7179785 0.78 DRD2 (0.43) KDM4EMAPTLMNATAAR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268652-A2 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2011-01-05 EP disclosed
WO-2009118475-A2 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-10-01 WO disclosed